ARBUTUS Trademark

Trademark Overview

On Friday, March 3, 2017, a trademark application was filed for ARBUTUS with the United States Patent and Trademark Office. The USPTO has given the ARBUTUS trademark a serial number of 87358040. The federal status of this trademark filing is REGISTERED as of Tuesday, November 13, 2018. This trademark is owned by Arbutus Biopharma Corporation. The ARBUTUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery for others in the nature of pharmaceutical research and development
arbutus

General Information

Serial Number87358040
Word MarkARBUTUS
Filing DateFriday, March 3, 2017
Status700 - REGISTERED
Status DateTuesday, November 13, 2018
Registration Number5607775
Registration DateTuesday, November 13, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 8, 2017

Trademark Statements

Goods and ServicesDrug discovery for others in the nature of pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, March 9, 2017
Primary Code042
First Use Anywhere DateSaturday, February 28, 2015
First Use In Commerce DateSaturday, February 28, 2015

Trademark Owner History

Party NameArbutus Biopharma Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWarminster, PA 18974
Party NameArbutus Biopharma Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBritish Columbia V5J5J8
CA
Party NameArbutus Biopharma Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBritish Columbia V5J5J8
CA

Trademark Events

Event DateEvent Description
Friday, January 5, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, November 13, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 3, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 3, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, August 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 13, 2018REGISTERED-PRINCIPAL REGISTER
Friday, October 12, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 11, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 4, 2018STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 27, 2018USE AMENDMENT FILED
Thursday, October 4, 2018SOU EXTENSION 2 GRANTED
Thursday, September 27, 2018SOU EXTENSION 2 FILED
Thursday, October 4, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 27, 2018SOU TEAS EXTENSION RECEIVED
Thursday, September 27, 2018TEAS STATEMENT OF USE RECEIVED
Thursday, April 5, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 3, 2018SOU EXTENSION 1 GRANTED
Tuesday, April 3, 2018SOU EXTENSION 1 FILED
Tuesday, April 3, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, October 3, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 8, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 8, 2017PUBLISHED FOR OPPOSITION
Wednesday, July 19, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 30, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, May 30, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 30, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, May 30, 2017EXAMINERS AMENDMENT -WRITTEN
Friday, May 26, 2017ASSIGNED TO EXAMINER
Thursday, March 9, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 7, 2017NEW APPLICATION ENTERED

Related Keywords

arbutus research development pharmaceutical nature discovery others drug